{
    "clinical_study": {
        "@rank": "98985", 
        "arm_group": [
            {
                "arm_group_label": "1 BI 113608", 
                "arm_group_type": "Active Comparator", 
                "description": "powder in the bottle for oral solution, oral administration with 240 mL water"
            }, 
            {
                "arm_group_label": "2 BI 113608", 
                "arm_group_type": "Experimental", 
                "description": "conventional tablet formulation"
            }, 
            {
                "arm_group_label": "3 BI 113608", 
                "arm_group_type": "Experimental", 
                "description": "conventional tablet formulation, fed"
            }, 
            {
                "arm_group_label": "4 BI 113608", 
                "arm_group_type": "Experimental", 
                "description": "conventional tablet after pantoprazole administration"
            }, 
            {
                "arm_group_label": "5 BI 113608", 
                "arm_group_type": "Experimental", 
                "description": "conventional tablet formulation, fasted, 0:30 min before fat breakfast"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the trial is to investigate the relative bioavailability, influence of\n      pantoprazole coadministration and food effect of different oral formulations of BI 113608 in\n      healthy male subjects"
        }, 
        "brief_title": "Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        1. healthy male subjects\n\n        Exclusion criteria:\n\n        1. Any relevant deviation from healthy conditions"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01703858", 
            "org_study_id": "1314.3", 
            "secondary_id": "2012-002537-11"
        }, 
        "intervention": [
            {
                "arm_group_label": "1 BI 113608", 
                "description": "powder for oral solution", 
                "intervention_name": "BI 113608 PIB", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2 BI 113608", 
                "description": "conventional tablet formulation", 
                "intervention_name": "BI 113608", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "3 BI 113608", 
                "description": "conventional tablet formulation", 
                "intervention_name": "BI 113608", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "5 BI 113608", 
                "description": "conventional tablet formulation", 
                "intervention_name": "BI 113608", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "4 BI 113608", 
                "description": "film-coated tablet", 
                "intervention_name": "pantoprazole 40 mg STADA", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "4 BI 113608", 
                "description": "conventional tablet formulation", 
                "intervention_name": "BI 113608", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Pantoprazole"
        }, 
        "lastchanged_date": "July 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ingelheim", 
                    "country": "Germany"
                }, 
                "name": "1314.3.1 Boehringer Ingelheim Investigational Site"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "5", 
        "official_title": "An Open Label, Randomised, Single Dose, 3-way Cross Over Study to Investigate Relative Bioavailability and Food Effect on Different Formulations of BI 113608 in Healthy Male Subjects, Followed by Fixed Sequence Periods Investigating Influence of Pantoprazole Coadministration and Food Effect on Pharmacokinetics of Different Formulations of BI 113608", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "AUC0-tz (area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point)", 
                "safety_issue": "No", 
                "time_frame": "up to 20 weeks"
            }, 
            {
                "measure": "Cmax (maximum measured concentration of the analyte in plasma)", 
                "safety_issue": "No", 
                "time_frame": "up to 20 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01703858"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "AUC0-8 (area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity)", 
            "safety_issue": "No", 
            "time_frame": "up to 20 weeks"
        }, 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}